2-piperidone has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelbary, AA; Aboumanei, MH; El-Kolaly, MT; Ibrahim, IT; Tadros, MI | 1 |
| Jadhav, RL; Magdum, CS; Patil, MV | 1 |
2 other study(ies) available for 2-piperidone and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Design and development of microemulsion systems of a new antineoplaston A10 analog for enhanced intravenous antitumor activity: In vitro characterization, molecular docking,
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Drug Compounding; Emulsions; Ethanol; Female; Histone Deacetylases; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; MCF-7 Cells; Microscopy, Electron, Transmission; Molecular Docking Simulation; Piperidones; Polysorbates; Rabbits; Repressor Proteins; Technology, Pharmaceutical; Tissue Distribution | 2018 |
Synthesis and anticancer evaluation of furfurylidene 4-piperidone analogs.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Survival; Doxorubicin; Drug Design; Fluorouracil; Humans; K562 Cells; Male; Mice; Molecular Structure; Piperidones; Structure-Activity Relationship; Time Factors; Tumor Burden | 2014 |